Compared with patients initiated on insulin, patients initiated on SGLT2i had a higher prevalence of CV comorbidities and proteinuria, whereas patients initiated on GLP1RA had a higher prevalence of obesity. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.